ArticleslgStudy

science

WAY-267464

WAY-267464 is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand WAY-267464 rather than just read about it. In short: WAY-267464 is a potent, selective, non-peptide agonist for the oxytocin receptor, with negligible affinity for the vasopressin receptors. However, though originally described as selective for the oxytocin receptor and lacking affinity for the vasopressin receptors, it has since been reported to also act as a potent vasopressin V1A receptor antagonist (in contrast to oxytocin, which is a weak agonist of the V1A recep…

WAY-267464 — main illustration
WAY-267464 — illustration

Key takeaways

  • WAY-267464 belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect WAY-267464 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of WAY-267464 from memory before moving on to harder problems.

Reference excerpt

WAY-267464 is a potent, selective, non-peptide agonist for the oxytocin receptor, with negligible affinity for the vasopressin receptors. However, though originally described as selective for the oxytocin receptor and lacking affinity for the vasopressin receptors, it has since been reported to also act as a potent vasopressin V1A receptor antagonist (in contrast to oxytocin, which is a weak agonist of the V1A receptor). WAY-267464 has been shown to cross the blood–brain barrier to a significantly greater extent than exogenously applied oxytocin, and in animal tests produces centrally-mediated oxytocinergic actions such as anxiolytic effects, but with no antidepressant effect evident. It was developed by a team at Ferring Pharmaceuticals. WAY-267464 was under investigation for the potential clinical treatment of anxiety disorders by Wyeth, and reached the preclinical stage of development, but no development has been reported as of 2011.

See also Oxytocin receptor agonist TC OT 39 LIT-001 KNX-100

References

Illustrations

WAY-267464 illustration

Worked examples

Example 1 — a first encounter with WAY-267464

Start with the simplest possible case. Write down what WAY-267464 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to WAY-267464 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about WAY-267464 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of WAY-267464

In research
WAY-267464 appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses WAY-267464 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
WAY-267464 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Anxiolytics, Benzamides, Drugs not assigned an ATC code, so understanding it makes those chapters shorter.
In everyday life
Look for WAY-267464 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “WAY-267464” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study WAY-267464 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what WAY-267464 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain WAY-267464 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is WAY-267464 in simple terms?

WAY-267464 is a potent, selective, non-peptide agonist for the oxytocin receptor, with negligible affinity for the vasopressin receptors. However, though originally described as selective for the oxytocin receptor and lacking affinity for the vasopressin receptors, it has since been reported to als…

Why does WAY-267464 matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study WAY-267464?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on WAY-267464.

Tags

  • Anxiolytics
  • Benzamides
  • Drugs not assigned an ATC code
  • Genito-urinary system drug stubs
  • Oxytocin receptor agonists
  • Piperazines
  • Psychoactive drug stubs
  • Pyrazolobenzodiazepines
  • Resorcinols
  • Vasopressin receptor antagonists

Keep exploring